Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrufin Plc Regulatory News (TRU)

Share Price Information for Trufin Plc (TRU)

Share Price is delayed by 15 minutes
Get Live Data
134.00    0.00 (0.00%)
Bid:
133.00
Ask:
135.00
Spread: 2.00 (1.504%)
Market Cap: £126.23m
TRU Live PriceLast checked at - London Stock Exchange

Intraday Trufin Plc Share Chart

Statement regarding Satago and Trading Update

10 Dec 2021 07:00

RNS Number : 2038V
TruFin PLC
10 December 2021
 

10 December 2021

 

TruFin plc("TruFin" or the "Company")

 

Statement regarding Satago and Trading Update

 

Statement regarding Satago

The Company announces that Satago Financial Solutions Limited ("Satago") has broadened its relationship with Lloyds Bank plc ("Lloyds Bank" or the "Bank") and extended its commercial pilot.

As part of the continued partnership, additional functionality within Satago is now being evaluated by Lloyds Bank as part of a broader remit within the commercial banking offering.

TruFin is also pleased to announce that Satago has completed its integration with Business Finance Assistant (the Bank's proprietary Accounting Software Solution) for Business Banking customers. This integration will broaden the digitised functionality offered to the Bank's Business Banking customers, providing seamless access to working capital.

As a result of the extended scope of the initiative, the commercial pilot phase will continue into early 2022.

Trading Update

During the second half of 2021, the gross revenue of Oxygen Finance Group Limited (together with its subsidiaries, Oxygen Finance Limited, Oxygen Finance Americas Inc. and Porge Limited) ("Oxygen") is expected to grow in excess of 30% over the same period in 2020. Oxygen's client base is expected to exceed 120 unique clients by year end (31 December 2020: 92). This positive momentum has resulted in Oxygen posting its first cash flow positive month during Q4 2021.

Oxygen continues to dominate the markets within which it operates, whilst delivering meaningful social value as it accelerates payments to thousands of suppliers in local economies. Oxygen expects to deliver revenue growth in excess of 20% per annum over the coming years, which, given the operational gearing in the business, should translate to increasing profits. Oxygen is fully funded for this organic growth, requiring no further financial support from TruFin.

The launch of Mortal Shell at Playstack Ltd ("Playstack") on the 'Steam Platform' occurred in August 2021 and negotiations to extend the franchise are ongoing. The pipeline of console IP remains strong and Playstack is well positioned to capitalise on recent successes with a number of further console signings expected over the next few months. The beta launch of the brand technology platform 'Interact' occurred in late November 2021 and a formal launch is expected to occur in Q1 2022. 

Vertus Capital Limited ("Vertus") has maintained its record of no credit losses since inception and, despite two early loan repayments, is still targeting a loan book of £22m by the end of Q1 2022 (from £12m as at 31 December 2020) and has a three-year loan book target of £50m. Vertus will be investing in technology-enabled lending solutions during 2022 to satisfy the growing pipeline and has recorded its first month of profitability during Q4 2021.

It is pleasing to report that two of our subsidiaries have recorded their first profitable months during 2021. However, the broadening and extension of Satago's commercial trial will result in the financial benefits of a successful commercial outcome being pushed back. The extended scope of the initiative has enlarged the opportunity set for Satago and this, coupled with Satago's increasing pipeline of strategic partners, gives the Board of TruFin confidence in the significant value creation opportunity at Satago.

We look forward to updating shareholders as to the result of the enlarged trial in early 2022.

The information contained within this Announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No.596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019. By the publication of this Announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. The person responsible for arranging for the release of this Announcement on behalf of the Company is Annie Styler.

For further information, please contact:

TruFin plcJames van den Bergh, Chief Executive OfficerKam Bansil, Investor Relations

0203 743 134007779 229508

Liberum Capital Limited (Nominated Adviser and Corporate broker)Chris ClarkeEdward ThomasChris Whittaker

0203 100 2000

TruFin plc is the holding company for an operating group of companies that are niche lenders and early payment providers. TruFin Group combines the benefits of both the traditional relationship banking model and developments in the fintech sector. The Company was admitted to AIM in February 2018 and trades under the ticker symbol: TRU. More information is available on the Company website www.TruFin.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBKLLBFLLZFBQ
Date   Source Headline
21st May 20267:00 amRNSProposed disposal of Playstack Limited
11th May 20264:49 pmRNSNotice of AGM
17th Apr 20267:00 amRNSBlock Admission Six Monthly Return
2nd Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Mar 20267:00 amRNSFinal Results for the 12 months ended 31 Dec 2025
5th Mar 20267:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Mar 20262:22 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20267:23 amRNSHolding(s) in Company
13th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
11th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Feb 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jan 20267:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 20267:02 amRNSPlaystack Management Incentive Plan
23rd Jan 20267:01 amRNSShare Buyback Programme
23rd Jan 20267:00 amRNSPlaystack Platform Contract
15th Jan 20267:00 amRNSTrading Update
11th Dec 20257:00 amRNSTrading Update
30th Oct 202510:47 amRNSBlock Admission Six Monthly Return
14th Oct 20254:22 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20257:01 amRNSHolding(s) in Company
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Oct 20257:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.